Evidence map›Paper›PMID 29288927›Full record

ArticleRedox biology2018

Novel H

Dan Wu, Qingxun Hu, Ying Xiong, Deqiu Zhu, Yicheng Mao, Yi Zhun Zhu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Redox biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. HBiomolecules · 2021
    Review
  10. Review
  11. Trends in HAntioxidants (Basel, Switzerland) · 2021
    Review
  12. The Cardiovascular Effects of Hydrogen Sulfide: The Epigenetic Mechanisms.Advances in experimental medicine and biology · 2021
    Article
  13. Highly efficient HChemical science · 2020
    Article
  14. Review
  15. Advances in the Protective Mechanism of NO, HFrontiers in cardiovascular medicine · 2020
    Review
  16. Review
  17. Review
  18. Article
  19. Hydrogen Sulfide (HFrontiers in pharmacology · 2018
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Dan WuDepartment of Pharmacy, Tongji Hospital, Tongji University School of Medicine, Shanghai, China; School of Pharmacy, Macau University of Science and Technology, Macau, China.
Qingxun HuShanghai Key Laboratory of Bioactive Small Molecules, Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, China; Mitochondria and Metabolism Center, Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, USA.
Ying XiongShanghai Key Laboratory of Bioactive Small Molecules, Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, China.
Deqiu ZhuDepartment of Pharmacy, Tongji Hospital, Tongji University School of Medicine, Shanghai, China.
Yicheng MaoShanghai Key Laboratory of Bioactive Small Molecules, Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai, China. Electronic address: maoyc@fudan.edu.cn.
Yi Zhun ZhuSchool of Pharmacy, Macau University of Science and Technology, Macau, China. Electronic address: yzzhu@must.edu.mo.
Fudan University · CNMacau University of Science and Technology · MOSeattle University · USTongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Therapeutic strategies that increase hydrogen sulfide (H

Indexed as

AnimalsAntioxidantsCardiotonic AgentsCystathionine gamma-LyaseGlutathione PeroxidaseHeart FailureHeme Oxygenase-1HumansHydrogen SulfideMembrane ProteinsMiceNitric OxideNitric Oxide Synthase Type IIIAntioxidantsCardiotonic AgentsCystathionine gamma-LyaseGlutathione PeroxidaseHeme Oxygenase-1Hmox1 protein, mouseHydrogen SulfideMembrane ProteinsNitric OxideNitric Oxide Synthase Type IIIHeart failureHydrogen sulfideNitric oxide

Identifiers

PMID29288927
PMCPMC5975222
OpenAlexW2774663054

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.